Immediate Impact
1 from Science/Nature 60 standout
Citing Papers
Therapeutic advances of targeting receptor tyrosine kinases in cancer
2024 Standout
Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms
2023 Standout
Works of Selina Moy being referenced
Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor
2020
Proarrhythmic Safety of Repeat Doses of Mirabegron in Healthy Subjects: A Randomized, Double-Blind, Placebo-, and Active-Controlled Thorough QT Study
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Selina Moy | 30 | 129 | 45 | 109 | 67 | 16 | 371 | |
| R Pompeius | 10 | 123 | 77 | 95 | 89 | 16 | 402 | |
| Nima Memaran | 3 | 103 | 49 | 22 | 30 | 23 | 379 | |
| Minjie Zhou | 8 | 27 | 40 | 54 | 22 | 22 | 351 | |
| James Dickinson | 19 | 56 | 122 | 45 | 33 | 14 | 337 | |
| D. Gangji | 13 | 75 | 20 | 45 | 55 | 19 | 324 | |
| C.S. Kwon | 3 | 22 | 74 | 35 | 31 | 21 | 345 | |
| R. Leroyer | 14 | 35 | 202 | 73 | 41 | 20 | 410 | |
| Irene Tamanini | 2 | 69 | 49 | 53 | 80 | 22 | 307 | |
| Omri Nativ | 4 | 24 | 73 | 14 | 33 | 24 | 339 | |
| Shuiming Guo | 10 | 9 | 39 | 26 | 66 | 19 | 370 |
All Works
Loading papers...